Management of Heparin Therapy
Authors:
- Edwin W. SalzmanESEdwin W. Salzman
- Daniel DeykinDDDaniel Deykin
- Ruth Mayer ShapiroRSRuth Mayer Shapiro
- Robert RosenbergRRRobert Rosenberg
- 15 May 1975
- journal article
- clinical trial
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 292 (20) , 1046-1050
Abstract
Among 100 consecutive patients receiving heparin in therapeutic dosage, major bleeding occurred in 21, and minor bleeding in 16. Two patients died from bleeding, and two had recurrent pulmonary embolism. Major bleeding occurred in 21% when therapy was regulated with whole-blood clotting time and in 20% when heparin was given without clotting tests.Keywords
This publication has 12 references indexed in Scilit:
- Drug Spotlight Program: Guidelines for Heparin TherapyAnnals of Internal Medicine, 1974
- Control of Heparin TherapyBMJ, 1970
- AnnotationBritish Journal of Haematology, 1970
- The Use of HeparinNew England Journal of Medicine, 1969
- Activated coagulation time of whole bloodJAMA, 1966
- Clinical experiences of a surgeon in the use of heparinThe American Journal of Cardiology, 1964
- Studies in Intravascular CoagulationCirculation, 1955
- Nine Years' Experience with Heparin in Acute Venous ThrombosisAngiology, 1950
- HEPARIN AS A PROPHYLACTIC AGAINST THROMBOSISJAMA, 1941
- HEPARIN IN SURGICAL TREATMENT OF BLOOD VESSELSArchives of Surgery, 1940